theophylline has been researched along with regadenoson in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Lera Ruiz, M; Lim, YH; Zheng, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Demkow, M; Kępka, C; Kruk, M; Marczak, M; Miłosz-Wieczorek, B; Oleksiak, A; Śpiewak, M | 1 |
| Page, RL; Pham, VA; Quaife, RA; Raines, J; Shakowski, C | 1 |
2 review(s) available for theophylline and regadenoson
| Article | Year |
|---|---|
Adenosine A2A receptor as a drug discovery target.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction | 2014 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for theophylline and regadenoson
| Article | Year |
|---|---|
Safety of regadenoson with theophylline reversal during dynamic computed tomography perfusion and magnetic resonance imaging in patients with coronary artery disease.
Topics: Coronary Artery Disease; Female; Humans; Magnetic Resonance Imaging; Myocardial Perfusion Imaging; Perfusion; Prospective Studies; Purines; Pyrazoles; Theophylline; Tomography, Emission-Computed, Single-Photon | 2020 |
Safety and efficacy of IV theophylline for regadenoson-associated side effect reversal.
Topics: Aminophylline; Drug-Related Side Effects and Adverse Reactions; Humans; Purines; Pyrazoles; Theophylline | 2023 |